Pharmacological Research

EDITORIAL: HEALTH IMPLICATIONS OF DHA
pp. 203-203(1)
Author: GALLI C.

EDITORIAL:HEALTH BENEFITS OF DOCOSAHEXAENOIC ACID (DHA)
pp. 205-206(2)
Author: LAGARDE M.

EDITORIAL:IS IT REALLY TIME TO PERFORM LARGE INTERVENTION TRIALS WITH ANTIOXIDANT VITAMINS TO PREVENT CARDIOVASCULAR DISEASE?
pp. 207-208(2)
Author: BELLOMO G.

EDITORIAL:ANTIOXIDANT VITAMINS AND CARDIOVASCULAR DISEASE
pp. 209-210(2)
Authors: KATAN M.B.; ZOCK P.L.

HEALTH BENEFITS OF DOCOSAHEXAENOIC ACID (DHA)
pp. 211-225(15)
Authors: HORROCKS L.A.; YEO Y.K.

ANTIOXIDANT VITAMINS AND PREVENTION OF CARDIOVASCULAR DISEASE: LABORATORY, EPIDEMIOLOGICAL AND CLINICAL TRIAL DATA
pp. 227-238(12)
Author: MARCHIOLI R.

METAL CHELATORS/ANTIOXIDANTS: APPROACHES TO PROTECT ERYTHROCYTIC OXIDATIVE STRESS INJURY DURING PLASMODIUM BERGHEI INFECTION IN MASTOMYS COUCHA
pp. 239-241(3)
Authors: SRIVASTAVA P.J.; CHANDRA S.; ARIF A.J.; SINGH C.; PANDAY V.

ANTI-ULCER ACTIVITY OF SKP-450, A NOVEL POTASSIUM CHANNEL ACTIVATOR, IN RATS
pp. 243-248(6)
Authors: CHEON H.G.; KIM H.J.; MO H.K.; YOO S.E.; LEE B.H.

EFFECTS OF NICERGOLINE ON THE RETINAL AND CORTICAL ELECTROPHYSIOLOGICAL RESPONSES IN GLAUCOMA PATIENTS: A PRELIMINARY OPEN STUDY
pp. 249-255(7)
Authors: PARISI V.; COLACINO G.; MILAZZO G.; SCUDERI A.C.; MANNI G.

NEUROCHEMICAL STUDIES WITH THE ANTICONVULSANT FELBAMATE IN MOUSE BRAIN
pp. 257-261(5)
Authors: FRASER C.M.; SILLS G.J.; FORREST G.; THOMPSON G.G.; BRODIE M.J.

CHRONIC NICOTINE PRETREATMENT PROTECTS THE BLOOD-BRAIN BARRIER AGAINST NICOTINE-INDUCED SEIZURES IN THE RAT
pp. 263-269(7)
Authors: UZUM G.; DILER A.S.; ZIYLAN Y.Z.

EFFECTS OF EARLY POSTNATAL EXPOSURE TO LOW CONCENTRATIONS OF CARBON MONOXIDE ON COGNITIVE FUNCTIONS IN RATS
pp. 271-274(4)
Authors: TATTOLI M.; CARRATU M.R.; CASSANO T.; CORTESE I.; DI GIOVANNI V.; ELIA G.; RENNA G.; CAGIANO R.

INHIBITION BY LEVAMISOLE OF THE ORGANIC CATION TRANSPORTER rOCT1 IN CULTURED RAT HEPATOCYTES
pp. 275-279(5)
Authors: MARTEL F.; RIBEIRO L.; CALHAU C.; AZEVEDO I.

PHARMACOKINETICS OF DOXORUBICIN INCORPORATED IN SOLID LIPID NANOSPHERES (SLN)
pp. 281-286(6)
Authors: ZARA G.P.; CAVALLI R.; FUNDARO A.; BARGONI A.; CAPUTO O.; GASCO M.R.

PHARMACOSURVEILLANCE IN HOSPITALIZED PATIENTS IN ITALY. STUDY DESIGN OF THE `GRUPPO ITALIANO DI FARMACOVIGILANZA NELL'ANZIANO' (GIFA)
pp. 287-295(9)
Authors: CAROSELLA L.; PAHOR M.; PEDONE C.; ZUCCALA G.; MANTO A.; CARBONIN P.; INVESTIGATORS G.

EFFECT OF THE MEGLITINIDE ANALOG S214O3 ON CATIONIC FLUXES AND INSULIN RELEASE IN PERIFUSED RAT PANCREATIC ISLETS EXPOSED TO A HIGH CONCENTRATION OF D-GLUCOSE
pp. 297-300(4)
Authors: LOUCHAMI K.; JIJAKLI H.; MALAISSE W.J.